Prof. Dr. Paul-Georg Germann
Angestellt, Global Head, Chemical & Preclinical Safety (CPS), Merck Health Care KGaA, Merck Healthcare KGaA, Darmstadt, Germany
Darmstadt, Deutschland
Werdegang
Berufserfahrung von Paul-Georg Germann
Bis heute 6 Jahre und 6 Monate, seit Nov. 2017
Global Head, Chemical & Preclinical Safety (CPS), Merck Health Care KGaA
Merck Healthcare KGaA, Darmstadt, Germany
Strategically and content wise leading a global unit for Chemical and Preclinical Safety with 126 FTE, covering Preclinical Safety Assessment for all Aspects of Chemical and Preclinical Safety in the indication fields of Oncology, Immunooncology and Immunology. Chemical Safety Assessments for high performance materials with respect to ecotoxicology and REACH.
3 Jahre und 10 Monate, Jan. 2014 - Okt. 2017
Head of Preclinical Safety Germany, AbbVie GmbH & Co.KG, Germany
AbbVie Deutschland GmbH & Co. KG1 Jahr und 3 Monate, Okt. 2012 - Dez. 2013
Leading New Frontiers Science Europe for Takeda Pharmaceuticals
Takeda Pharmaceuticals International AGVice President New Frontier Science Europe Takeda Pharmaceuticals, September 2012 – Present, Europe Scope of New Frontier Science: Bring very early science and groundbreaking innovation from academia and start ups into the value stream of a large pharmaceutical company. Create value through leveraging international connections within the academic community. Looking for platform technologies, focused therapies or healthcare concepts.
4 Jahre und 9 Monate, Jan. 2008 - Sep. 2012
Leading Discovery to Proof of Concept Development Organisation
Nycomed GmbH
01.12.2007-30.09.2012: Vice President “Discovery to Proof of Concept Development” Organisation, Nycomed a Takeda Company, Constance, Germany (Lead of R&D organisation with 5 multinational sites (Germany, Denmark, India) and approx. 450 employees, annual budget responsibility: 80 Mio.€; 01.03.2007-30.11.2007: Managing director and Vice President of “In vivo Efficacy & Safety”, 73 colleagues from pharmacology department in Constance reporting directly to Prof. Dr. Germann (approx. 220 employees in total).
2 Jahre und 7 Monate, Juni 2005 - Dez. 2007
Managing Director Institute for Pharmacology & Preclinical Safety
Altana Pharma
8 Jahre und 5 Monate, Jan. 1991 - Mai 1999
Senior Pathologist
Byk Gulden Pharmaceuticals
Ausbildung von Paul-Georg Germann
6 Jahre und 6 Monate, Apr. 1994 - Sep. 2000
Master of Science Appl.Toxicology
Universitiy of Guilford
Toxicology and Risk Assessment
5 Jahre und 3 Monate, Okt. 1982 - Dez. 1987
Veterinärmedizin
Tierärztliche Hochschule Hannover
Pathology Toxicological Pathology Tumor and cell differentiation
Sprachen
Deutsch
-
Englisch
Fließend